Related Experiment Video
Updated: Oct 21, 2025

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Hypoglossal Nerve Stimulator-Induced Neurapraxia Following Electrical Cardioversion for Atrial Fibrillation
Christian S Yacono1, Matthew C Hyman1
1Division of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Electrical cardioversion for atrial fibrillation can cause hypoglossal nerve stimulator-associated neurapraxia in patients with obstructive sleep apnea. This complication requires careful consideration during treatment planning.
Area of Science:
- Neurology
- Cardiology
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) is increasingly treated with hypoglossal nerve stimulators (HNS).
- Atrial fibrillation (AF) is a common comorbidity in patients with OSA.
- Electrical cardioversion is a standard procedure for managing atrial fibrillation.
Observation:
- A case of neurapraxia associated with a hypoglossal nerve stimulator is presented.
- This complication occurred after electrical cardioversion for atrial fibrillation in an OSA patient.
Findings:
- Hypoglossal nerve stimulator implantation is associated with potential neurological complications.
- Electrical cardioversion may precipitate or exacerbate neurapraxia in patients with HNS.
Implications:
- Clinicians should be aware of the risk of HNS-associated neurapraxia after electrical cardioversion.
- Further research is needed to understand the mechanism and prevention of this complication.
- This case highlights the importance of a multidisciplinary approach in managing patients with OSA and AF.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation III: AED Use
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

